1. Home
  2. CTBI vs IMCR Comparison

CTBI vs IMCR Comparison

Compare CTBI & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$70.92

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$32.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTBI
IMCR
Founded
1903
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
CTBI
IMCR
Price
$70.92
$32.29
Analyst Decision
Buy
Buy
Analyst Count
3
13
Target Price
★ $81.33
$62.73
AVG Volume (30 Days)
119.6K
★ 503.3K
Earning Date
10-21-2026
11-05-2026
Dividend Yield
★ 4.16%
N/A
EPS Growth
17.79
★ 30.39
EPS
★ 3.14
0.23
Revenue
N/A
★ $249,428,000.00
Revenue This Year
$10.44
$13.06
Revenue Next Year
$4.55
$8.12
P/E Ratio
★ $21.73
$139.20
Revenue Growth
N/A
★ 43.05
52 Week Low
$50.25
$27.50
52 Week High
$79.92
$40.71

Technical Indicators

Market Signals
Indicator
CTBI
IMCR
Relative Strength Index (RSI) 39.59 57.89
Support Level $64.34 $32.03
Resistance Level $71.28 $33.62
Average True Range (ATR) 1.99 1.24
MACD -0.41 0.53
Stochastic Oscillator 41.92 76.67

Price Performance

Historical Comparison
CTBI
IMCR

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: